Related Experiment Video
Updated: Jul 20, 2026
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
In vitro pyrogen test--A new test method for solid medical devices
Francesca Mazzotti1, Julia Beuttler, Richard Zeller
1Biochemical Pharmacology, University of Konstanz, Germany.
Abstract:
Medical devices manufactured for implantation into humans must be free of any contamination with viable bacteria. However, remnants of dead bacteria and bacterial components alone may induce an inflammatory immune response. Pyrogen tests for such inflammatory contaminations are generally performed either by determining the content of lipopolysaccharide in rinsing solutions of batch samples by limulus amoebocyte lysate assay, by injecting the rinsing solutions into rabbits or by implanting batch samples into rabbits and measuring change of body temperature. In this study, we show that the in vitro pyrogen test (IPT), which measures the release of the inflammatory cytokine IL-1beta in fresh or cryopreserved human whole blood, can be used to assess the pyrogenic contamination of implantable medical devices. This test was used to check neurosurgical implants, namely aneurysm clips, as a proof of principle. Owing to the direct contact of the test material with the blood cells, this test does not require rinsing procedures, which have variable efficacy. The use of human blood ensures the detection of all substances that are pyrogenic for humans and reflects their relative potency. The safety of the products as delivered could be confirmed. The effects of sterilization and depyrogenization procedures on intentional pyrogenic contaminations of samples could be followed. This new application of the already internationally validated method promises to replace further rabbit pyrogen tests. It generates extremely sensitive results with an extended range of detectable pyrogenic contaminants.
Insights
The in vitro pyrogen test (IPT) using human blood effectively detects inflammatory contaminants on medical devices. This validated method offers a sensitive alternative to traditional rabbit pyrogen tests for implantable device safety.
Area of Science:
- Biomedical Engineering
- Immunology
- Microbiology
Background:
- Implantable medical devices require stringent pyrogen testing to prevent adverse immune reactions.
- Current pyrogen tests (LAL assay, rabbit models) have limitations in sensitivity and applicability.
- Bacterial remnants, not just viable bacteria, can trigger inflammatory responses.
Purpose of the Study:
- To evaluate the in vitro pyrogen test (IPT) for assessing pyrogenic contamination in implantable medical devices.
- To demonstrate the efficacy of IPT using neurosurgical implants as a proof of principle.
- To establish IPT as a reliable replacement for animal-based pyrogen testing.
Main Methods:
- Utilized an in vitro pyrogen test (IPT) measuring IL-1beta release in human whole blood.
- Applied IPT to assess pyrogenic contamination on neurosurgical aneurysm clips.
- Compared IPT performance against traditional pyrogen testing methods.
Main Results:
- IPT successfully detected pyrogenic contamination on implantable medical devices.
- The test demonstrated high sensitivity and a broad detection range for pyrogenic contaminants.
- IPT eliminated the need for variable rinsing procedures by direct material-blood contact.
- The safety of sterilized and depyrogenized products was confirmed.
Conclusions:
- The in vitro pyrogen test (IPT) is a validated and sensitive method for detecting pyrogenic contamination on medical devices.
- IPT offers a human-relevant, efficient, and ethical alternative to animal-based pyrogen testing.
- This application of IPT enhances the safety assessment of implantable medical devices.
Related Concept Videos
01:24Automated Microbial Diagnostics
01:25Rapid Identification of Pathogens